235 related articles for article (PubMed ID: 21261712)
1. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations.
Hirst NG; Gordon LG; Whiteman DC; Watson DI; Barendregt JJ
J Gastroenterol Hepatol; 2011 Feb; 26(2):247-54. PubMed ID: 21261712
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
Gerson LB; Groeneveld PW; Triadafilopoulos G
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):868-79. PubMed ID: 15476150
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.
Gordon LG; Mayne GC; Hirst NG; Bright T; Whiteman DC; ; Watson DI
Gastrointest Endosc; 2014 Feb; 79(2):242-56.e6. PubMed ID: 24079411
[TBL] [Abstract][Full Text] [Related]
5. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
Benaglia T; Sharples LD; Fitzgerald RC; Lyratzopoulos G
Gastroenterology; 2013 Jan; 144(1):62-73.e6. PubMed ID: 23041329
[TBL] [Abstract][Full Text] [Related]
6. Improving cost-effectiveness of endoscopic surveillance for Barrett's esophagus by reducing low-value care: a review of economic evaluations.
Vissapragada R; Bulamu NB; Brumfitt C; Karnon J; Yazbeck R; Watson DI
Surg Endosc; 2021 Nov; 35(11):5905-5917. PubMed ID: 34312726
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
Streitz JM; Ellis FH; Tilden RL; Erickson RV
Am J Gastroenterol; 1998 Jun; 93(6):911-5. PubMed ID: 9647017
[TBL] [Abstract][Full Text] [Related]
8. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
Barbiere JM; Lyratzopoulos G
Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
[TBL] [Abstract][Full Text] [Related]
10. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?
Inadomi JM; Saxena N
Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571
[TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
12. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.
Shaheen NJ; Inadomi JM; Overholt BF; Sharma P
Gut; 2004 Dec; 53(12):1736-44. PubMed ID: 15542506
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
[TBL] [Abstract][Full Text] [Related]
14. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
15. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
[TBL] [Abstract][Full Text] [Related]
16. Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model.
Furneri G; Klausnitzer R; Haycock L; Ihara Z
PLoS One; 2019; 14(3):e0212916. PubMed ID: 30865673
[TBL] [Abstract][Full Text] [Related]
17. How to get the most out of costly Barrett's oesophagus surveillance.
Braden B; Jones-Morris E
Dig Liver Dis; 2018 Sep; 50(9):871-877. PubMed ID: 29730158
[TBL] [Abstract][Full Text] [Related]
18. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
19. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
20. Are screening and surveillance for Barrett's oesophagus really worthwhile?
Sharma P; Sidorenko EI
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]